Table 8. Treatment Options for Women With Axillary Node-Positive Breast Cancer
| Patient group | Treatments |
| a Note: This treatment option is under clinical evaluation. | |
| Premenopausal, ER-positive or PR-positive | Chemotherapy plus tamoxifen, chemotherapy plus ovarian ablation/GnRH analog, chemotherapy plus tamoxifen plus ovarian ablation/GnRH analog,a ovarian ablation alone or with tamoxifen or GnRH alone or with tamoxifen |
| Premenopausal, ER-negative or PR-negative | Chemotherapy |
| Postmenopausal, ER-positive or PR-positive | Tamoxifen plus chemotherapy, tamoxifen alone |
| Postmenopausal, ER-negative or PR-negative | Chemotherapy |
| Older than 70 years | Tamoxifen alone; consider chemotherapy if receptor-negative |
